<DOC>
	<DOCNO>NCT02016157</DOCNO>
	<brief_summary>In Randomized clinical trial locally deliver moxifloxacin situ gel evaluate adjunct scale root plan efficacy treatment chronic periodontitis short-term effect periodontal microflora .</brief_summary>
	<brief_title>Moxifloxacin Situ Gel Treat Periodontal Pocket .</brief_title>
	<detailed_description>Moxifloxacin exert excellent antibacterial activity wide range putative periodontal pathogen , include Porphyromonas gingivalis , Tannerella forsythia , Prevotella specie , Fusobacterium nucleatum , Actinomyces specie , Peptostreptococcus specie , Campylobacter rectus , Actinobacillus actinomycetemcomitans . Moxifloxacin penetrate well soft tissue effective intracellular periodontal pathogen use treatment periodontitis adjunct scale root planning ( SRP ) . Systemic administration moxifloxacin provide superior outcome compare SRP conjunction systemic administration doxycycline , SRP alone . We hypothesize similar benefit local drug delivery Moxifloxacin treatment chronic periodontitis . To best knowledge , publish literature situ gel use moxifloxacin employ gellan gum vehicle , direct placement periodontal pocket treatment chronic periodontitis . Among various drug delivery system treat periodontitis , gel formulation advantage . Despite relatively fast release drug , gel easily prepare administer . Moreover , posse high bio compatibility bio adhesivity , allow adhesion mucosa dental pocket decrease risk dilution material saliva . Keeping fact mind , goal study ( 1 ) evaluate situ gel vehicle local drug delivery system , ( 2 ) evaluate efficacy moxifloxacin local drug delivery , ( 3 ) evaluate efficacy gellan gum situ gelation moxifloxacin , ( 4 ) evaluate compare clinical microbiological parameter moxifloxacin gold standard , chlorhexidine di gluconate .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Periodontal Pocket</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>patient good systemic health Patients Chronic periodontitis sit probe pocket depth ( PPD ) â‰¥ 5 mm minimum 12 natural teeth radiographic evidence bone loss willingness comply study protocol . Patients history drug allergy quinolones take medication might interact moxifloxacin Patients history antibiotic coverage 6 month precede study Pregnant lactating patient .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Moxifloxacin</keyword>
	<keyword>Chlorhexidine</keyword>
	<keyword>In situ gel</keyword>
	<keyword>Chronic periodontitis</keyword>
</DOC>